FOCAL CRYOTHERAPY FOR LOW- TO INTERMEDIATE-RISK PROSTATE CANCER: LONG TERM RESULTS AND MATCHED PAIR COMPARISON WITH ACTIVE SURVEILLANCE

被引：0
|
作者：
Marra, Giancarlo
Soeterik, Timo
Oreggia, Davide
Pasquali, Caio
Tourinho-Barbosa, Rafael
Moschini, Marco
Filippini, Claudia
van Melick, Harm H. E.
van den Bergh, Roderick C. N.
Gontero, Paolo
Cathala, Nathalie
Macek, Petr
Sanchez-Salas, Rafael
Cathelineau, Xavier
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP46-10
引用
收藏
页码：E817 / E817
页数：1
相关论文
共 50 条
  • [21] Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study
    Rakauskas, Arnas
    Tawadros, Thomas
    Lucca, Ilaria
    Herrera, Fernanda
    Bourhis, Jean
    Burruni, Rodolfo
    Gomes, Maria Natal
    Codeluppi, Caroline
    Jolliet, Laura
    La Rosa, Stefano
    Meuwly, Jean Yves
    Jichlinski, Patrice
    Berthold, Dominik
    Valerio, Massimo
    [J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2021, 62 (04) : 416 - 422
  • [22] Influence of Active Surveillance on Gleason Score Upgrade and Prognosis in Low- and Favorable Intermediate-Risk Prostate Cancer
    Hu, Xuanhan
    Miao, Jia
    Huang, Jiaqing
    Qian, Lin
    Zhang, Dahong
    Wei, Haibin
    [J]. CURRENT ONCOLOGY, 2022, 29 (10) : 7964 - 7978
  • [23] Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance
    Whalen, Michael J.
    Pak, Jamie S.
    Lascano, Danny
    Ahlborn, David
    Matulay, Justin T.
    McKiernan, James M.
    Benson, Mitchell C.
    Wenske, Sven
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : E425 - E435
  • [24] Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
    Albers, Peter
    Wiegel, Thomas
    Schmidberger, Heinz
    Bussar-Maatz, Roswitha
    Haerter, Martin
    Kristiansen, Glen
    Martus, Peter
    Meisner, Christoph
    Wellek, Stefan
    Grozinger, Klaus
    Renner, Peter
    Burmester, Martin
    Schneider, Fried
    Stoeckle, Michael
    [J]. WORLD JOURNAL OF UROLOGY, 2021, 39 (01) : 65 - 72
  • [25] Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
    Peter Albers
    Thomas Wiegel
    Heinz Schmidberger
    Roswitha Bussar-Maatz
    Martin Härter
    Glen Kristiansen
    Peter Martus
    Christoph Meisner
    Stefan Wellek
    Klaus Grozinger
    Peter Renner
    Martin Burmester
    Fried Schneider
    Michael Stöckle
    [J]. World Journal of Urology, 2021, 39 : 65 - 72
  • [26] Long-term results of definitive conformal percutaneous radiation in locally confined low- and intermediate-risk prostate cancer
    Deichmueller, C.
    Wegener, G.
    Karstens, J. H.
    Bruns, F.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 118 - 118
  • [27] Results of active surveillance in low and intermediate risk prostate cancer
    Llorente, Carlos
    Diaz Goizueta, Francisco Javier
    Hernandez, Virginia
    Manuel de la Morena, Jose
    de la Pena, Enrique
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2014, 67 (05): : 452 - 456
  • [28] Oncologic outcomes of radiation therapy following active surveillance for low- and intermediate-risk localized prostate cancer.
    Ahmad, Ardalan
    Chua, Melvin
    Murgic, Jure
    Raziee, Hamid Reza
    Hosni, Ali
    De Moraes, Fabio Ynoe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [29] SBRT in low- and intermediate-risk prostate cancer: results of a phase II study
    D'Agostino, G.
    Villa, E.
    Franzese, C.
    Liardo, R.
    Reggiori, G.
    Navarria, P.
    Iftode, C.
    De Rose, F.
    Franceschini, D.
    Tozzi, A.
    Comito, T.
    Ascolese, A.
    Tomatis, S.
    Scorsetti, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S628 - S629
  • [30] Editorial Comment to "A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer"
    Matsumoto, Ryuji
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (03) : 297 - 297
12345